Cargando…

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

OBJECTIVE: The objective of this study was to quantify the impact that longer battery life of cardiac resynchronization therapy defibrillator (CRT-D) devices has on reducing the number of device replacements and associated costs of these replacements from a Swedish health care system perspective. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadler, Fredrik, Ding, Yao, Verin, Nathalie, Bergius, Martin, Miller, Jeffrey D, Lenhart, Gregory M, Russell, Mason W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096753/ https://www.ncbi.nlm.nih.gov/pubmed/27826203 http://dx.doi.org/10.2147/CEOR.S114921

Ejemplares similares

The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives
por: Landolina, Maurizio, et al.
Publicado: (2017)

Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods
por: Valzania, Cinzia, et al.
Publicado: (2008)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators
por: Magnusson, Peter, et al.
Publicado: (2016)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Left-bundle branch block, an alert for cardiac resynchronization therapy
por: Gatti, P, et al.
Publicado: (2023)

A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
por: Tomini, F., et al.
Publicado: (2016)

Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database
por: Boriani, Giuseppe, et al.
Publicado: (2016)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia
por: Kim, Hak Ju, et al.
Publicado: (2016)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Implantation of a cardiac resynchronization therapy and defibrillation system using a robotic approach
por: Amraoui, Sana, et al.
Publicado: (2015)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
por: Hadwiger, Moritz, et al.
Publicado: (2022)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
por: Theuns, Dominic A.M.J., et al.
Publicado: (2011)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy
por: Ogano, Michio, et al.
Publicado: (2018)

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
por: Christie, Simon, et al.
Publicado: (2018)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Right ventricular dominant myocarditis requiring cardiac resynchronization therapy‐defibrillator: a case report
por: Sato, Takanori, et al.
Publicado: (2021)

Magnetic resonance imaging in a patient with cardiac resynchronization therapy‐defibrillator and two abandoned leads
por: Lüsebrink, Enzo, et al.
Publicado: (2022)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Editorial to implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Minamiguchi, Hitoshi
Publicado: (2019)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
por: Sardu, Celestino, et al.
Publicado: (2017)

Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices
por: Miyazawa, Kazuo, et al.
Publicado: (2021)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Efficacy of cardiac resynchronization with defibrillator insertion in patients undergone coronary artery bypass graft: A cohort study of cardiac function
por: Karbasi-Afshar, Reza, et al.
Publicado: (2015)

Benefit of magnetic resonance–conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis–involved cervical extradural lesion
por: Kawakami, Hiroshi, et al.
Publicado: (2015)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
por: Barakpour, Hamid, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_96siv9go69p4khttqd9r742ph2